S. Fransen

发表

Machine learning enables detection of early-stage colorectal cancer by whole-genome sequencing of plasma cell-free DNA

Gabriel E. Sanderson, Nathan Boley, Yaping Liu, 2018, BMC Cancer.

Combinations of Mutations in the Connection Domain of Human Immunodeficiency Virus Type 1 Reverse Transcriptase: Assessing the Impact on Nucleoside and Nonnucleoside Reverse Transcriptase Inhibitor Resistance

C. Petropoulos, E. Paxinos, E. Stawiski, 2010, Antimicrobial Agents and Chemotherapy.

Suppression of Dualtropic Human Immunodeficiency Virus Type 1 by the CXCR4 Antagonist AMD3100 Is Associated with Efficiency of CXCR4 Use and Baseline Virus Composition

C. Petropoulos, N. Parkin, E. Stawiski, 2008, Antimicrobial Agents and Chemotherapy.

Coreceptor Tropism Can Be Influenced by Amino Acid Substitutions in the gp41 Transmembrane Subunit of Human Immunodeficiency Virus Type 1 Envelope Protein

C. Petropoulos, N. Parkin, E. Stawiski, 2008, Journal of Virology.

Longitudinal Analysis of Raltegravir Susceptibility and Integrase Replication Capacity of Human Immunodeficiency Virus Type 1 during Virologic Failure

C. Charpentier, C. Petropoulos, Wei Huang, 2009, Antimicrobial Agents and Chemotherapy.

RANTES production by T cells and CD8-mediated inhibition of human immunodeficiency virus gene expression before initiation of potent antiretroviral therapy predict sustained suppression of viral replication.

K. Rosenthal, F. Smaill, M. Smieja, 2000, The Journal of infectious diseases.

Characterization of human immunodeficiency virus type 1 populations containing CXCR4-using variants from recently infected individuals.

T. Wrin, C. Petropoulos, F. Hecht, 2009, AIDS research and human retroviruses.

Coreceptor Tropism Can Be Inﬂuenced by Amino Acid Substitutions in the gp41 Transmembrane Subunit of Human Immunodeﬁciency Virus Type 1 Envelope Protein (cid:1)

C. Petropoulos, N. Parkin, E. Stawiski, 2008 .

Development and Characterization of a Novel Single-Cycle Recombinant-Virus Assay To Determine Human Immunodeﬁciency Virus Type 1 Coreceptor Tropism (cid:1)

T. Wrin, C. Petropoulos, E. Paxinos, 2007 .

Cross-Resistance to Elvitegravir Confer Resistance to Raltegravir and Secondary Amino Acid Substitutions and Preferentially Associated with Specific Acid Position 143 of HIV-1 Integrase Are Multiple Genetic Pathways Involving Amino

Wei Huang, S. Fransen, J. Christos, 2014 .

Multiple Genetic Pathways Involving Amino Acid Position 143 of HIV-1 Integrase Are Preferentially Associated with Specific Secondary Amino Acid Substitutions and Confer Resistance to Raltegravir and Cross-Resistance to Elvitegravir

C. Petropoulos, Wei Huang, S. Fransen, 2013, Antimicrobial Agents and Chemotherapy.

Minimal sequence variability of the region of HIV-1 integrase targeted by the Abbott RealTime HIV-1 viral load assay in clinical specimens with reduced susceptibility to raltegravir.

N. Parkin, J. Hackett, G. Cloherty, 2013, Journal of virological methods.

Loss of Raltegravir Susceptibility by Human Immunodeficiency Virus Type 1 Is Conferred via Multiple Nonoverlapping Genetic Pathways

Christos J. Petropoulos, Wei Huang, D. Hazuda, 2009, Journal of Virology.

Evolution of Integrase Resistance During Failure of Integrase Inhibitor-Based Antiretroviral Therapy

Jeffrey N. Martin, C. Petropoulos, H. Hatano, 2010, Journal of acquired immune deficiency syndromes.

A pilot study of nevirapine, indinavir, and lamivudine among patients with advanced human immunodeficiency virus disease who have had failure of combination nucleoside therapy.

J. Montaner, B. Conway, J. Raboud, 1998, The Journal of infectious diseases.

Machine learning enables detection of early-stage colorectal cancer by whole-genome sequencing of plasma cell-free DNA

Gabriel E. Sanderson, Nathan Boley, Yaping Liu, 2018, bioRxiv.

Coreceptor Tropism in Human Immunodeficiency Virus Type 1 Subtype D: High Prevalence of CXCR4 Tropism and Heterogeneous Composition of Viral Populations

Wei Huang, Christos J. Petropoulos, Susan H. Eshleman, 2007, Journal of Virology.

Co-receptor Tropism in Subtype D HIV-1 : High Prevalence of CXCR 4 Tropism and Heterogeneous Composition of Viral Populations

C. Petropoulos, E. Paxinos, N. Parkin, 2007 .

Development and Characterization of a Novel Single-Cycle Recombinant-Virus Assay To Determine Human Immunodeficiency Virus Type 1 Coreceptor Tropism

Christos J. Petropoulos, Terri Wrin, Wei Huang, 2006, Antimicrobial Agents and Chemotherapy.

Stavudine plus lamivudine in advanced human immunodeficiency virus disease: a short-term pilot study.

J. Montaner, D. Rouleau, B. Conway, 1997, The Journal of infectious diseases.

Transmission of Integrase Strand-Transfer Inhibitor Multidrug-Resistant HIV-1: Case Report and Response to Raltegravir-Containing Antiretroviral Therapy

C. Petropoulos, B. Ha, B. Young, 2011, Antiviral therapy.

Performance of the Abbott RealTime HIV-1 Viral Load Assay Is Not Impacted by Integrase Inhibitor Resistance-Associated Mutations

N. Parkin, J. Hackett, G. Cloherty, 2011, Journal of Clinical Microbiology.

Mutational pathways and genetic barriers to CXCR4-mediated entry by human immunodeficiency virus type 1.

C. Petropoulos, E. Stawiski, Wei Huang, 2011, Virology.

Differential impact of test performance characteristics on burden-to-benefit tradeoffs for blood-based colorectal cancer screening: A microsimulation analysis

R. Meester, S. Fransen, G. Putcha, 2023, Journal of medical screening.

Connection Domain Mutations in HIV-1 Reverse Transcriptase Do Not Impact Etravirine Susceptibility and Virologic Responses to Etravirine-Containing Regimens

R. Paredes, B. Clotet, J. Schapiro, 2011, Antimicrobial Agents and Chemotherapy.

Substitutions at Amino Acid Positions 143, 148, and 155 of HIV-1 Integrase Define Distinct Genetic Barriers to Raltegravir Resistance In Vivo

Wei Huang, Christos J. Petropoulos, Arne Frantzell, 2012, Journal of Virology.

Primary lamivudine resistance in acute/early human immunodeficiency virus infection.

J. Montaner, D. Rouleau, B. Conway, 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Performance of the Abbott RealTime HIV-1 Viral Load Assay Is Not Impacted by Integrase Inhibitor Resistance-Associated Mutations

N. Parkin, J. Hackett, G. Cloherty, 2011, Journal of Clinical Microbiology.

Loss of Raltegravir Susceptibility by Human Immunodeficiency Virus Type 1 Is Conferred via Multiple Nonoverlapping Genetic Pathways

D. Hazuda, C. Petropoulos, R. Danovich, 2009, Journal of Virology.

C. Petropoulos, Wei Huang, S. Fransen, 2013, Antimicrobial Agents and Chemotherapy.

C. Petropoulos, E. Paxinos, E. Stawiski, 2010, Antimicrobial Agents and Chemotherapy.

Performance Characteristics and Validation of the PhenoSense HIV Integrase Assay

S. Fransen, 2008 .